This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr. Michelle Janas, Lead Scientist, GE Healthcare Life Sciences (Photo: Business Wire)

Dr. Michelle Janas from GE Healthcare Life Sciences recently swapped a lab coat for legislation, when she visited Jenny Willott MP at the House of Commons for a “Week in Westminster” as part of a unique ‘pairing’ scheme run by the Royal Society – the UK’s national academy of science.
Dr. Michelle Janas, Lead Scientist, GE Healthcare Life Sciences (Photo: Business Wire)

Dr. Michelle Janas, Lead Scientist, GE Healthcare Life Sciences (Photo: Business Wire)

Dr. Janas is a Lead Scientist at GE Healthcare’s laboratories in Cardiff, Wales, where she is part of the team pioneering new technologies for cell therapy. During her visit, she shadowed Ms Willott MP to learn about her work. She also attended a House of Commons Science and Technology Committee meeting and Prime Minister’s Question Time, and met with Professor Sir John Beddington, Government Chief Scientific Advisor. The visit provided Dr. Janas with a behind-the-scenes insight into how science policy is formed as well as an understanding of the working life of an MP. Under the pairing scheme, Ms Willott will make a reciprocal visit to GE Healthcare.

Cell therapy, the use of cells to replace damaged tissue or treat disease, has the potential to help millions of patients suffering from life-threatening and life-limiting diseases like cancer and heart disease. Very much at the cutting edge of medicine, the UK Government recently announced a £50m investment into a new cell therapy technology innovation centre. GE Healthcare has established a global Centre of Excellence for Cell Technology Research at its facility in Cardiff, Wales.

Dr. Janas said: “I believe scientists have a role to play in helping to make innovations like cell therapy a reality through engagement with politicians and policy makers. It is exciting to be sharing my scientific experience with Ms Willott MP and I’m keen to further my understanding of how science policy is developed and communicated to the wider community.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs